Keywords: EU Commission, Antitrus complaint, Johnson & Johnson, Novartis, Fentanyl, Janssen Cilag, Sandoz

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis

Article | 01 February 2013

Print This

The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug major Novartis (NOVN: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in